Idorsia Ltd

Idorsia Ltd is a biopharmaceutical company incorporated on October 2, 2017. The headquarters of Idorsia is situated in Allschwil, Switzerland. The company primarily engages in the discovery, development, and commercialization of small molecules for the treatment of diseases with significant unmet medical needs in the biopharmaceutical sector. At the current stage of its business, Idorsia is in the process of late-stage clinical development for its most advanced candidates, focusing on potential future brands that may be approved and marketed. The company's efforts are geared toward achieving regulatory approvals in various regions, which would include key pharmaceutical markets that could potentially involve the United States, European countries, and other regions contingent on successful clinical trial outcomes and the subsequent green light from regulatory bodies. (Powered by AI)